Cardiovascular implants Market: By Type (Coronary Stents, Peripheral Stents, Heart Valves, Implanted Cardiac Pacemakers, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy (CRT) Device), By End User (Hospitals, Ambulatory Surgical Centre, Cardiac Centers) and By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Cardiovascular implants Market is expected to grow at a CAGR of 7% during the forecast period 2023 to 2029. Cardiovascular implants have been brought into clinical practice for an expansive range of signs. Cardiovascular implants can be embedded in relatively every area all through the cardiovascular framework. Adjacent to the careful course, numerous different ways and strategies have been produced for acquiring the embed to its predetermination the human body. Heart specialists, vessel specialists, neurosurgeons, radiologists, cardiologists and pediatric cardiologists routinely perform implantations of a huge assortment of gadgets into veins or into the heart. Global cardiovascular implants market expected to grow at significant rate owing to increase in cases heart failure around the world. Cardiovascular implants are the one of the promising treatment option for the heart failure patients. Market has many of the players and comprising of huge competition among them. Companies are collaborating to other technological companies in development of the new and innovative products for company market growth. In 2017, Abbott has secured U.S. Food and Drug Administration (FDA) clearance for the Confirm Rx Insertable Cardiac Monitor (ICM), the world's first and only smartphone compatible ICM designed to help physicians remotely identify cardiac arrhythmias

Cardiovascular Implants Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7%

Largest Market

North America

Fastest Growing Market

Europe

Cardiovascular implants Market Dynamics

Global cardiovascular implants market is driven by growing aging population who are very susceptible to the heart related diseases and technological developments in cardiovascular implants that minimizing the chances of infection and improved efficiency of devices Furthermore, cardiovascular implants are one of the more reliable and efficient options for the heart failure management. However, factors such as availability of alternative treatment options expected to hinder the market growth. Furthermore chances of infection, high cost of cardiovascular implants and stringent regulatory procedures may act as restraints for the growth of global cardiovascular implants market over the forecast period.

Cardiovascular Implants Market Segmentation

By Type

  • Coronary Stents, Peripheral Stents
  • Heart Valves
  • Implanted Cardiac Pacemakers
  • Implantable Cardioverter Defibrillator
  • Cardiac Resynchronization Therapy (CRT) Device

By End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Cardiac Centers

BY Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

The key segments covered in the Cardiovascular implants Market are: by type, by end user

The Cardiovascular implants Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Europe is the fastest-growing for Cardiovascular implants Market

Key Features of the Report

  • The cardiovascular implants market report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market
1.Executive Summary
2.Global Cardiovascular implants Market Introduction 
2.1.Global Cardiovascular implants Market  - Taxonomy
2.2.Global Cardiovascular implants Market  - Definitions
2.2.1.Type
2.2.2.End User
2.2.3.Region
3.Global Cardiovascular implants Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Cardiovascular implants Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Cardiovascular implants Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Coronary Stents, Peripheral Stents
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Heart Valves
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Implanted Cardiac Pacemakers
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Implantable Cardioverter Defibrillator
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Cardiac Resynchronization Therapy (CRT) Device
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Cardiovascular implants Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Ambulatory Surgical Centres
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cardiac Centers
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Cardiovascular implants Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Cardiovascular implants Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Coronary Stents, Peripheral Stents
8.1.2.Heart Valves
8.1.3.Implanted Cardiac Pacemakers
8.1.4.Implantable Cardioverter Defibrillator
8.1.5.Cardiac Resynchronization Therapy (CRT) Device
8.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Ambulatory Surgical Centres
8.2.3.Cardiac Centers
8.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Cardiovascular implants Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Coronary Stents, Peripheral Stents
9.1.2.Heart Valves
9.1.3.Implanted Cardiac Pacemakers
9.1.4.Implantable Cardioverter Defibrillator
9.1.5.Cardiac Resynchronization Therapy (CRT) Device
9.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Ambulatory Surgical Centres
9.2.3.Cardiac Centers
9.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
10.Asia Pacific (APAC) Cardiovascular implants Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Coronary Stents, Peripheral Stents
10.1.2.Heart Valves
10.1.3.Implanted Cardiac Pacemakers
10.1.4.Implantable Cardioverter Defibrillator
10.1.5.Cardiac Resynchronization Therapy (CRT) Device
10.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Ambulatory Surgical Centres
10.2.3.Cardiac Centers
10.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Cardiovascular implants Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Coronary Stents, Peripheral Stents
11.1.2.Heart Valves
11.1.3.Implanted Cardiac Pacemakers
11.1.4.Implantable Cardioverter Defibrillator
11.1.5.Cardiac Resynchronization Therapy (CRT) Device
11.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Ambulatory Surgical Centres
11.2.3.Cardiac Centers
11.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Cardiovascular implants Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Coronary Stents, Peripheral Stents
12.1.2.Heart Valves
12.1.3.Implanted Cardiac Pacemakers
12.1.4.Implantable Cardioverter Defibrillator
12.1.5.Cardiac Resynchronization Therapy (CRT) Device
12.2.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Ambulatory Surgical Centres
12.2.3.Cardiac Centers
12.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Calon Cardio-Technology Ltd. (U.K.
13.2.2.SynCardia Systems, Inc. (U.S.)
13.2.3.Medtronic (U.S.)
13.2.4.Berlin Heart GmbH (Germany)
13.2.5.CHF Solutions, Inc. (U.S.)
13.2.6.Teleflex Incorporated (U.S.)
13.2.7.MAQUET GmbH & Co. (Germany)
13.2.8.Abiomed (U.S.)
13.2.9.Abbot Laboratories (U.S.)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Calon Cardio-Technology Ltd. (U.K.
  • SynCardia Systems, Inc. (U.S.)
  • Medtronic (U.S.)
  • Berlin Heart GmbH (Germany)
  • CHF Solutions, Inc. (U.S.)
  • Teleflex Incorporated (U.S.)
  • MAQUET GmbH & Co. (Germany)
  • Abiomed (U.S.)
  • Abbot Laboratories (U.S.)

Adjacent Markets